Arun Azad

37PUBLICATIONS
153CO-AUTHORS
Predictive and prognostic markersMolecular targetsRadiation therapyToxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Sep 27, 2026
Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

|Aug 27, 2026
Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate Cancer.

|Jul 08, 2026
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Jun 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Apr 14, 2026
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer.

Abdullah Al-Khanaty, David Chen, Jonathan Walbaum

Pageof 7

Frequent Collaborators

8 joint publications

Michael S Hofman

7 joint publications

Declan G Murphy

7 joint publications

Edmond M Kwan

5 joint publications

Neeraj Agarwal